MedTech Dive April 18, 2024
Susan Kelly

Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

Dive Brief:

  • Scientific instruments maker Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression, Nanostring said Wednesday.
  • The sale will conclude Nanostring’s bankruptcy proceeding and restructuring process, the Seattle-based company said. When it filed for Chapter 11 protection in February, Nanostring disclosed it had received multiple early indications of interest from possible acquirers.
  • Bruker’s acquisition, which includes the assumption of certain liabilities, will allow Nanostring’s business operations and product development initiatives to continue for customers and substantially all of the company’s employees,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
FDA considers 2nd blood test for colon cancer — but advisers note concerns
Intertronics acquires Dyne Testing
NICE, NHS England unveil new pathway for medtech
UK regulator proposes recognizing overseas medical device approvals
GE HealthCare tops FDA list for AI-enabled medical device authorizations (again)

Share This Article